Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Innovative Therapies in Europe
Session 8: Emerging EU HTA - Will Joint Scientific Consultations and Joint Clinical Assessments on the European level enable faster and broader patient access to ATMPs?
Session Chair(s)
Vanessa Elisabeth Schaub
- Global Access Senior Health Systems Strategy Leader HTA & Reimbursement
- F. Hoffmann-La Roche, Switzerland
Topics covered in this session include:
- What is the EC’s vision for accelerated patient access in Europe by moving to a European HTA approach?
- How a flexible yet predictable should HTA approach for ATMPs look like?
- Will JSC help early alignment for non-traditional evidence requirements and needs?
- Which role will RWE & Registries play along the product life cycle to close data gaps?